Novo Nordisk (NYSE: NVO), the Danish company behind popular diabetes drug Ozempic and anti-obesity medication Wegovy, has become one of the most valuable businesses in the world. Worth approximately $580 billion already, the company has achieved considerable gains for its shareho…
Read More
About The Author
